Showing results (181-190 of 503) with videos related to
Sort By:
Pageof 51
International Journal of MS Care|November 3, 2016
Disability Progression After Switching from Natalizumab to Fingolimod or Interferon Beta/Glatiramer Acetate Therapies: A NARCOMS AnalysisStacey S Cofield, Robert J Fox, Tuula Tyry, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 11, 2017
Landscape of MS patient cohorts and registries: Recommendations for maximizing impactBruce F Bebo, Robert J Fox, Karen Lee, et al.Neurology. Clinical Practice|August 26, 2024
Access to Care and Health-Related Quality of Life in Multiple SclerosisRuth Ann Marrie, Samantha Lancia, Gary R Cutter, et al.Medical Physics|July 13, 2018
Technical Note: Retrospective reduction in systematic differences across scanner changes by accounting for noise floor effects in diffusion tensor imagingKen Sakaie, Xiaopeng Zhou, Jian Lin, et al.Neurology|April 8, 2025
Perspectives of People With Multiple Sclerosis Regarding Data Linkage and SharingRuth Ann Marrie, Mudita Sharma, Gary R Cutter, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 13, 2012
The effect of plasma exchange on serum anti-JC virus antibodiesMeena Subramanyam, Tatiana Plavina, Bhupendra O Khatri, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 3, 2025
Post-acute sequela of COVID-19 infection in individuals with multiple sclerosisAmber Salter, Samantha Lancia, Gary R Cutter, et al.Frontiers in Neurology|January 3, 2022
Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple SclerosisRuth Ann Marrie, Casandra Dolovich, Gary R Cutter, et al.BMC Neurology|June 7, 2022
Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosisRobert J Fox, Rina Mehta, Timothy Pham, et al.Annals of Neurology|August 24, 2017
T1-/T2-weighted ratio differs in demyelinated cortex in multiple sclerosisKunio Nakamura, Jacqueline T Chen, Daniel Ontaneda, et al.Pageof 51